Anika to Participate in the 20th Annual Needham Virtual Healthcare Conference
Anika Therapeutics (NASDAQ: ANIK) has announced that Dr. Cheryl Blanchard, President and CEO, and Michael Levitz, CFO, will present at the 20th Annual Needham Virtual Healthcare Conference on April 15, 2021, at 3:45 p.m. ET.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Anika Therapeutics (NASDAQ: ANIK) has announced that Dr. Cheryl Blanchard, President and CEO, and Michael Levitz, CFO, will present at the 20th Annual Needham Virtual Healthcare Conference on April 15, 2021, at 3:45 p.m. ET. The event will be accessible via a live audio webcast on Anika's Investor Relations website, and an audio archive will be available post-event.
As a leader in joint preservation, Anika focuses on developing innovative orthopedic solutions for osteoarthritis and soft tissue repair, enhancing patient outcomes and active living.
Details
News Market Reaction – ANIK
The recorded move for ANIK in the trading session of this news was +0.72%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
BEDFORD, Mass., April 05, 2021 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that Dr. Cheryl Blanchard, President and Chief Executive Officer and Michael Levitz, Executive Vice President, Chief Financial Officer and Treasurer, will present at the 20th Annual Needham Virtual Healthcare Conference on Thursday, April 15, 2021 at 3:45 p.m. ET.
A live audio webcast will be available in the Investor Relations section of Anika’s website, www.anika.com. An audio archive of the session will also be available on the website.
About Anika
Anika Therapeutics, Inc. (NASDAQ: ANIK), is a global joint preservation company that creates and delivers meaningful advancements in early intervention orthopedic care. We partner with clinicians to understand what they need most to treat their patients and we develop minimally invasive products that restore active living for people around the world. We are committed to leading in high opportunity spaces within orthopedics, including osteoarthritis pain management, regenerative solutions, soft tissue repair and bone preserving joint technologies. Anika is headquartered in Massachusetts with operations in the United States and Europe. For more information about Anika, please visit www.anika.com.
For Investor Inquiries:
Mark Namaroff
Anika Therapeutics, Inc.
Executive Director, Investor Relations and Corporate Communications
Direct: 781-457-9287
mnamaroff@anika.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.